BridgeBio Pharma

BBIO

Market cap $14.9B

Upgrade to unlock

Buy

Hold

Sell

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$96

26% upside

High target

8 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
JP Morgan Anupam Rama 100% 1-yr BBIO win rate				10 Mar ‘26 1 month ago
William Blair John Boylan 100% 1-yr BBIO win rate				10 Mar ‘26 1 month ago
Truist Securities Danielle Brill 75% 1-yr BBIO win rate				25 Feb ‘26 1 month ago
Oppenheimer Trevor Allred 50% 1-yr BBIO win rate				25 Feb ‘26 1 month ago
Morgan Stanley Sean Laaman 50% 1-yr BBIO win rate				25 Feb ‘26 1 month ago
Evercore ISI Group Cory Kasimov 100% 1-yr BBIO win rate				25 Feb ‘26 1 month ago
HC Wainwright & Co Raghuram Selvaraju 67% 1-yr BBIO win rate				17 Feb ‘26 2 months ago
Wells Fargo Derek Archila 33% 1-yr BBIO win rate				13 Feb ‘26 2 months ago
Barclays Eliana Merle 67% 1-yr BBIO win rate				28 Jan ‘26 2 months ago